[
  {
    "text": "There are 200 million clinical cases",
    "start": 13.754,
    "duration": 4.666
  },
  {
    "text": "of falciparum malaria\nin Africa every year,",
    "start": 18.444,
    "duration": 4.403
  },
  {
    "text": "resulting in half a million deaths.",
    "start": 22.871,
    "duration": 2.92
  },
  {
    "text": "I would like to talk to you\nabout malaria vaccines.",
    "start": 26.395,
    "duration": 3.809
  },
  {
    "text": "The ones that we have made to date\nare simply not good enough.",
    "start": 30.807,
    "duration": 5.598
  },
  {
    "text": "Why?",
    "start": 36.998,
    "duration": 1.15
  },
  {
    "text": "We've been working at it\nfor 100 plus years.",
    "start": 38.474,
    "duration": 3.984
  },
  {
    "text": "When we started, technology was limited.",
    "start": 42.95,
    "duration": 3.606
  },
  {
    "text": "We could see just a tiny fraction\nof what the parasite really looked like.",
    "start": 46.966,
    "duration": 6.881
  },
  {
    "text": "Today, we are awash with technology,",
    "start": 54.466,
    "duration": 3.365
  },
  {
    "text": "advanced imaging and omics platforms --",
    "start": 57.855,
    "duration": 4.055
  },
  {
    "text": "genomics, transcriptomics, proteomics.",
    "start": 61.934,
    "duration": 4.21
  },
  {
    "text": "These tools have given us a clearer view",
    "start": 66.62,
    "duration": 3.873
  },
  {
    "text": "of just how complex\nthe parasite really is.",
    "start": 70.517,
    "duration": 4.293
  },
  {
    "text": "However, in spite of this,",
    "start": 75.365,
    "duration": 2.627
  },
  {
    "text": "our approach to vaccine design\nhas remained pretty rudimentary.",
    "start": 78.016,
    "duration": 5.5
  },
  {
    "text": "To make a good vaccine,\nwe must go back to basics",
    "start": 84.04,
    "duration": 4.42
  },
  {
    "text": "to understand how our bodies\nhandle this complexity.",
    "start": 88.484,
    "duration": 4.525
  },
  {
    "text": "People who are frequently\ninfected with malaria",
    "start": 94.46,
    "duration": 4.197
  },
  {
    "text": "learn to deal with it.",
    "start": 98.681,
    "duration": 1.467
  },
  {
    "text": "They get the infection,\nbut they don't get ill.",
    "start": 100.689,
    "duration": 3.301
  },
  {
    "text": "The recipe is encoded in antibodies.",
    "start": 104.688,
    "duration": 3.619
  },
  {
    "text": "My team went back to our complex parasite,",
    "start": 108.903,
    "duration": 3.984
  },
  {
    "text": "probed it with samples from Africans\nwho had overcome malaria",
    "start": 112.911,
    "duration": 4.928
  },
  {
    "text": "to answer the question:",
    "start": 117.863,
    "duration": 1.825
  },
  {
    "text": "\"What does a successful\nantibody response look like?\"",
    "start": 119.712,
    "duration": 4.047
  },
  {
    "text": "We found over 200 proteins,",
    "start": 124.212,
    "duration": 3.302
  },
  {
    "text": "many of which are not\non the radar for malaria vaccines.",
    "start": 127.538,
    "duration": 4.213
  },
  {
    "text": "My research community may be missing out\nimportant parts of the parasite.",
    "start": 132.141,
    "duration": 5.182
  },
  {
    "text": "Until recently, when one had identified\na protein of interest,",
    "start": 138.283,
    "duration": 5.265
  },
  {
    "text": "they tested whether it might be\nimportant for a vaccine",
    "start": 143.572,
    "duration": 3.603
  },
  {
    "text": "by conducting a cohort study.",
    "start": 147.199,
    "duration": 2.429
  },
  {
    "text": "This typically involved about 300\nparticipants in a village in Africa,",
    "start": 150.307,
    "duration": 5.572
  },
  {
    "text": "whose samples were analyzed to see",
    "start": 155.903,
    "duration": 2.809
  },
  {
    "text": "whether antibodies to the protein\nwould predict who got malaria",
    "start": 158.736,
    "duration": 5.706
  },
  {
    "text": "and who did not.",
    "start": 164.466,
    "duration": 1.246
  },
  {
    "text": "In the past 30 years,",
    "start": 166.323,
    "duration": 2.103
  },
  {
    "text": "these studies have tested\na small number of proteins",
    "start": 168.45,
    "duration": 4.778
  },
  {
    "text": "in relatively few samples",
    "start": 173.252,
    "duration": 2.372
  },
  {
    "text": "and usually in single locations.",
    "start": 175.648,
    "duration": 2.667
  },
  {
    "text": "The results have not been consistent.",
    "start": 178.782,
    "duration": 3.079
  },
  {
    "text": "My team essentially collapsed\n30 years of this type of research",
    "start": 182.956,
    "duration": 6.081
  },
  {
    "text": "into one exciting experiment,\nconducted over just three months.",
    "start": 189.061,
    "duration": 4.941
  },
  {
    "text": "Innovatively, we assembled 10,000 samples",
    "start": 194.609,
    "duration": 4.222
  },
  {
    "text": "from 15 locations\nin seven African countries,",
    "start": 198.855,
    "duration": 4.413
  },
  {
    "text": "spanning time, age\nand the variable intensity",
    "start": 203.292,
    "duration": 4.222
  },
  {
    "text": "of malaria experienced in Africa.",
    "start": 207.538,
    "duration": 2.682
  },
  {
    "text": "We used omics intelligence\nto prioritize our parasite proteins,",
    "start": 210.585,
    "duration": 5.659
  },
  {
    "text": "synthesize them in the lab",
    "start": 216.268,
    "duration": 2.0
  },
  {
    "text": "and in short, recreated\nthe malaria parasite on a chip.",
    "start": 218.292,
    "duration": 4.804
  },
  {
    "text": "We did this in Africa,\nand we're very proud of that.",
    "start": 223.585,
    "duration": 3.467
  },
  {
    "text": "(Applause)",
    "start": 227.379,
    "duration": 6.175
  },
  {
    "text": "The chip is a small glass slide,",
    "start": 233.578,
    "duration": 3.111
  },
  {
    "text": "but it gives us incredible power.",
    "start": 236.713,
    "duration": 2.396
  },
  {
    "text": "We simultaneously gathered data\non over 100 antibody responses.",
    "start": 240.007,
    "duration": 6.167
  },
  {
    "text": "What are we looking for?",
    "start": 246.592,
    "duration": 1.6
  },
  {
    "text": "The recipe behind a successful\nantibody response,",
    "start": 248.679,
    "duration": 4.635
  },
  {
    "text": "so that we can predict\nwhat might make a good malaria vaccine.",
    "start": 253.338,
    "duration": 4.365
  },
  {
    "text": "We're also trying to figure out",
    "start": 258.68,
    "duration": 1.873
  },
  {
    "text": "exactly what antibodies\ndo to the parasite.",
    "start": 260.577,
    "duration": 3.547
  },
  {
    "text": "How do they kill it?",
    "start": 264.482,
    "duration": 1.555
  },
  {
    "text": "Do they attack from multiple angles?\nIs there synergy?",
    "start": 266.061,
    "duration": 3.722
  },
  {
    "text": "How much antibody do you need?",
    "start": 269.807,
    "duration": 2.0
  },
  {
    "text": "Our studies suggest that having\na bit of one antibody won't be enough.",
    "start": 272.188,
    "duration": 5.889
  },
  {
    "text": "It might take high\nconcentrations of antibodies",
    "start": 278.458,
    "duration": 3.183
  },
  {
    "text": "against multiple parasite proteins.",
    "start": 281.665,
    "duration": 2.516
  },
  {
    "text": "We're also learning that antibodies\nkill the parasite in multiple ways,",
    "start": 284.673,
    "duration": 5.015
  },
  {
    "text": "and studying any one of these in isolation\nmay not adequately reflect reality.",
    "start": 289.712,
    "duration": 5.944
  },
  {
    "text": "Just like we can now see the parasite\nin greater definition,",
    "start": 296.454,
    "duration": 4.476
  },
  {
    "text": "my team and I are focused",
    "start": 300.954,
    "duration": 1.992
  },
  {
    "text": "on understanding how our bodies\novercome this complexity.",
    "start": 302.97,
    "duration": 4.737
  },
  {
    "text": "We believe that this could provide\nthe breakthroughs that we need",
    "start": 308.012,
    "duration": 4.437
  },
  {
    "text": "to make malaria history\nthrough vaccination.",
    "start": 312.473,
    "duration": 3.736
  },
  {
    "text": "Thank you.",
    "start": 316.719,
    "duration": 1.151
  },
  {
    "text": "(Applause)",
    "start": 317.894,
    "duration": 1.703
  },
  {
    "text": "(Cheers)",
    "start": 319.621,
    "duration": 2.396
  },
  {
    "text": "(Applause)",
    "start": 322.041,
    "duration": 5.752
  },
  {
    "text": "Shoham Arad: OK, how close\nare we actually to a malaria vaccine?",
    "start": 327.817,
    "duration": 3.487
  },
  {
    "text": "Faith Osier: We're just\nat the beginning of a process",
    "start": 332.281,
    "duration": 2.857
  },
  {
    "text": "to try and understand\nwhat we need to put in the vaccine",
    "start": 335.162,
    "duration": 3.984
  },
  {
    "text": "before we actually start making it.",
    "start": 339.17,
    "duration": 2.533
  },
  {
    "text": "So, we're not really close to the vaccine,\nbut we're getting there.",
    "start": 341.727,
    "duration": 3.833
  },
  {
    "text": "SA: And we're hopeful.",
    "start": 345.584,
    "duration": 1.241
  },
  {
    "text": "FO: And we're very hopeful.",
    "start": 346.849,
    "duration": 1.8
  },
  {
    "text": "SA: Tell me about SMART,\ntell me what does it stand for",
    "start": 349.323,
    "duration": 3.246
  },
  {
    "text": "and why is it important to you?",
    "start": 352.593,
    "duration": 2.04
  },
  {
    "text": "FO: So SMART stands for South-South\nMalaria Antigen Research Partnership.",
    "start": 354.657,
    "duration": 6.383
  },
  {
    "text": "The South-South\nis referring to us in Africa,",
    "start": 361.477,
    "duration": 4.262
  },
  {
    "text": "looking sideways to each other\nin collaboration,",
    "start": 365.763,
    "duration": 4.505
  },
  {
    "text": "in contrast to always looking to America\nand looking to Europe,",
    "start": 370.292,
    "duration": 4.206
  },
  {
    "text": "when there is quite\nsome strength within Africa.",
    "start": 374.522,
    "duration": 3.037
  },
  {
    "text": "So in SMART,",
    "start": 377.997,
    "duration": 1.164
  },
  {
    "text": "apart from the goal that we have,\nto develop a malaria vaccine,",
    "start": 379.185,
    "duration": 3.94
  },
  {
    "text": "we are also training African scientists,",
    "start": 383.149,
    "duration": 2.445
  },
  {
    "text": "because the burden\nof disease in Africa is high,",
    "start": 385.618,
    "duration": 3.229
  },
  {
    "text": "and you need people who will continue\nto push the boundaries",
    "start": 388.871,
    "duration": 3.963
  },
  {
    "text": "in science, in Africa.",
    "start": 392.858,
    "duration": 1.658
  },
  {
    "text": "SA: Yes, yes, correct.",
    "start": 394.54,
    "duration": 2.046
  },
  {
    "text": "(Applause)",
    "start": 396.61,
    "duration": 3.191
  },
  {
    "text": "OK, one last question.",
    "start": 400.053,
    "duration": 1.548
  },
  {
    "text": "Tell me, I know you\nmentioned this a little bit,",
    "start": 401.625,
    "duration": 2.754
  },
  {
    "text": "but how would things actually change\nif there were a malaria vaccine?",
    "start": 404.403,
    "duration": 3.254
  },
  {
    "text": "FO: We would save\nhalf a million lives every year.",
    "start": 408.732,
    "duration": 3.738
  },
  {
    "text": "Two hundred million cases.",
    "start": 413.256,
    "duration": 1.826
  },
  {
    "text": "It's estimated that malaria costs Africa\n12 billion US dollars a year.",
    "start": 415.106,
    "duration": 6.808
  },
  {
    "text": "So this is economics.",
    "start": 422.278,
    "duration": 1.396
  },
  {
    "text": "Africa would simply thrive.",
    "start": 423.698,
    "duration": 2.268
  },
  {
    "text": "SA: OK. Thank you, Faith.",
    "start": 426.626,
    "duration": 1.501
  },
  {
    "text": "Thank you so much.",
    "start": 428.151,
    "duration": 1.198
  },
  {
    "text": "(Applause)",
    "start": 429.373,
    "duration": 1.396
  }
]